Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00487500 · ClinicalTrials.gov registry record · Phase 4
Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression
A Phase 4 study of Depression, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT00487500: Completed Phase 4 study of Depression, sponsored by New York State Psychiatric Institute.
NCT00487500 is a Phase 4 study of Depression that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 180 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00487500, a Phase 4 study of Depression, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare four types of electroconvulsive therapy to determine if they differ in their effects on mood, thinking, brain activity, and biochemistry in people with major depressive disorder.
Primary Outcome
Primary outcome reflected change in HRSD depression symptom scores.
Conditions Studied
Interventions
- DEVICE Electroconvulsive Therapy (ECT)
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 1998-12 |
| Est. Completion | 2005-05 |
| Phase | Phase 4 |
What the finished NCT00487500 record still lists
NCT00487500 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Electroconvulsive Therapy (ECT) is the first listed.
NCT00487500 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00487500 about?
NCT00487500 is a clinical study titled "Comparing the Effects of Four Types of Electroconvulsive Therapy on Mood and Thinking in People With Depression". This study will compare four types of electroconvulsive therapy to determine if they differ in their effects on mood, thinking, brain activity, and biochemistry in people with major depressive disorder.
What is the current status of trial NCT00487500?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 1998-12. Estimated completion is 2005-05.
What conditions does trial NCT00487500 study?
This clinical trial studies the following conditions: Depression.
What interventions are being tested in trial NCT00487500?
The interventions under investigation include: Electroconvulsive Therapy (ECT) (DEVICE).
Who is sponsoring clinical trial NCT00487500?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00487500 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00487500's enrollment target sits among peer trials
180 224th of 679 higher than 452 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
RECRUITING · Phase 4
-
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia